SpaceX Is Losing Money and Borrowing Billions. These 4 Profitable Aerospace Stocks Might Be Better Buys Right Now

The article contrasts SpaceX’s highly leveraged, cash-burning profile—raising $86B in its IPO and then adding $25B in bond refinancing, with Q1 2026 net losses of $4.28B and xAI generating $818M revenue vs $2.47B operating losses—against four more profitable aerospace/defense plays. It highlights RTX (Q1 2026 sales $22.1B, +9% YoY; Raytheon operating profit +24%; guided FY2026 adjusted sales $92B–$93B), Heico (Q2 FY2026 net income +49% YoY; net sales $1.375B, +25%), Curtiss-Wright (Q1 2026 sales $914M, +13%; operating margin 17.5%; EPS $3.46), and Hexcel (Q1 2026 net sales $501.5M, +9.9%; adjusted EPS $0.59, +14% vs estimates). Net impact is mainly stock-selection oriented, with moderate potential to move names highlighted due to strong operating updates and outlook.

Analysis

The real tradeable message is not “aerospace is strong”; it is that the market is likely to keep paying up for cash conversion, backlog quality, and maintenance content while discounting capital-intensive growth stories with refinancing risk. That structurally favors RTX and HEI: both monetize installed bases, which means margins can expand even when unit growth is modest, and both should be less exposed to a single delivery-cycle hiccup than OEM-adjacent names.

HXL is the cleanest cyclical lever, but it is also the most timing-sensitive: if Airbus/Boeing production ramps slip even one quarter, the equity can de-rate faster than the underlying demand thesis changes. CW sits further out on the duration curve; its defense/nuclear exposure should behave like a quasi-long-duration bond proxy inside industrials, so it benefits if budgets hold and rates drift lower, but it is vulnerable to multiple compression if Treasury yields stay sticky.

The contrarian risk is that the market may already own the “quality aerospace” trade, so the next leg is more about earnings revisions than narrative. Meanwhile, debt-heavy space exposure is path-dependent on capital markets; if credit spreads widen or growth decelerates, equity value can compress much faster than launch cadence or revenue growth would suggest. Watch for guidance cuts, delivery delays, or any sign that backlog conversion is worsening; those would falsify the bullish quality-premium view within 1-2 quarters.

Key Decisions for Investors

• Overweight RTX on any 2-3% pullback after the next print; target a 6-12 month re-rating driven by backlog conversion and defense margin mix. Falsify if adjusted sales or segment margin guidance stalls.
• Initiate a smaller long in HEI versus broad industrials (XLI) for a 3-6 month hold; this is the cleanest maintenance/aftermarket compounder. Risk is a sudden airline utilization slowdown or acquisition integration slip.
• Buy HXL only on weakness tied to OEM delivery concerns; use a tighter stop because this is the most ramp-sensitive name in the group. Best setup is 1-2 quarters ahead of visible widebody build-rate confirmation.
• If SPCX is liquid/shortable, pair long RTX or HEI against short SPCX as a quality-vs-leverage trade. This expresses the view that refinancing risk and negative operating leverage matter more than top-line hype over the next 6-18 months.
• Set a watch item on CW for Treasury yields and defense appropriations; if rates fall and guidance holds, it can work as a slower-moving compounder. If the stock rallies on the story before earnings inflect, wait for a better entry rather than chase.